Komori
Intramart (3850) · InitiativeFirst stated

Cross-functional digitalization of quality control operations at Taiho Pharmaceutical Co., Ltd.

First written in FY2027-H1. . Latest entry: FY2027-H1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Cross-functional digitalization of pharmaceutical quality management operationsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2027-H1First statedAnnual report

    「大鵬薬品工業株式会社 used “intra-mart” to digitize quality control operations specific to the pharmaceutical industry across functions, reducing work time by 74% for release decisions and by 78% for product quality reviews, thereby helping reduce workloads and optimize business processes.」

    Describes an implementation example in which “intra-mart” was used to digitize pharmaceutical-industry quality control operations across functions, reducing work time by 74% for release decisions and by 78% for product quality reviews.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Intramart yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Cross-functional digitalization of quality control operations at Taiho Pharmaceutical Co., Ltd. | INTRAMART CORPORATION (3850) | Komori